House of Reps demands urgent crackdown on fake drug syndicates

The House of Representatives has called for a more aggressive crackdown on the production and distribution of counterfeit and expired drugs in Nigeria, following the recent discovery of an illegal drug manufacturing facility in Osisioma Ngwa Local Government Area (LGA) of Abia State.
The resolution was moved by Hon. Nnamdi Ezechi, who raised alarms over the growing issue of fake pharmaceuticals during plenary in Abuja on Tuesday.
Ezechi revealed that the illegal factory, located in a remote village, was involved in rebranding expired drugs by altering their expiry dates and producing counterfeit medications, including injectables, which were being distributed to unsuspecting Nigerians.
“The consumption of fake and substandard drugs poses severe health risks, including treatment failures, drug resistance, and even death,” Ezechi stated.
The House expressed deep concern that the Osisioma Ngwa incident was not an isolated case but part of a broader public health crisis, as similar counterfeit drug operations have been uncovered across the country.
The lawmakers noted that the circulation of such harmful products has contributed to Nigeria’s high mortality rate, with citizens unknowingly consuming ineffective or toxic medications.
The House strongly condemned the production and distribution of fake drugs and commended law enforcement agencies for their efforts in uncovering the Abia State operation.
It urged the federal government to direct the National Agency for Food and Drug Administration and Control (NAFDAC), the Pharmacists Council of Nigeria (PCN), and other relevant agencies to intensify surveillance, inspections, and crackdowns on fake drug manufacturers and distributors nationwide.
Additionally, the House mandated its Committees on Health and Drugs and Narcotics to investigate the widespread issue of counterfeit drugs in the country.
It also called for increased public awareness campaigns on the dangers of fake drugs and the introduction of advanced tracking and authentication systems to help consumers verify the authenticity of pharmaceutical products before purchase.
The House also urged the Federal Ministry of Health, in collaboration with security agencies, to implement stricter penalties for individuals and organizations involved in the illegal drug trade, ensuring that offenders face the full weight of the law.